Watch NGVT. Know when insiders buy.
One email the day a filing lands. Free.
NGVT
Ingevity Corp
71.75
+2.79 +4.05%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
38
FLAG · shorts 38
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.5BP/E 47.8DIV YIELD —FCF YIELD 6.28%REV TTM $1.2B −1.4%NET INCOME $54MNET DEBT $958.8M52W 46.20 – 77.87SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $314.1M | −5.2% | 44.3% | — | $35.3M | — | 1.00 | −$13.8M | $10.3M | −$24.1M | Jul 30 |
| Q1 2026 · Mar 31 | $258M | +4.1% | 45.1% | — | $59.8M | +191.7% | 1.66 | −$2M | $10.3M | −$12.3M | Jul 30 |
| Q4 2025 · Dec 31derived | $255.1M | −3.1% | 34.4% | — | −$84.6M | −609.6% | -2.34 | $97.1M | $23.6M | $73.5M | Feb 26 |
| Q3 2025 · Sep 30 | $333.1M | −0.2% | 40.2% | — | $43.5M | — | 1.18 | $129.7M | $11.9M | $117.8M | Nov 6 |
| Q2 2025 · Jun 30 | $331.5M | −15.1% | 38.6% | — | −$146.5M | — | -4.02 | $79M | $12.2M | $66.8M | Jul 30 |
| Q1 2025 · Mar 31 | $247.9M | −27.1% | 45.1% | — | $20.5M | — | 0.56 | $25.4M | $10M | $15.4M | Jul 30 |
| Q4 2024 · Dec 31derived | $263.3M | — | 37.9% | $137.5M | $16.6M | — | 0.46 | $64.5M | $24.9M | $39.6M | Feb 26 |
| Q3 2024 · Sep 30 | $333.8M | −25.2% | 39.4% | $110.2M | −$107.2M | −525.4% | -2.94 | $46.5M | $18M | $28.5M | Nov 6 |
| Q2 2024 · Jun 30 | $390.6M | — | 31.5% | $101.3M | −$283.7M | — | -7.81 | $29.7M | $18.1M | $11.6M | Nov 6 |
| Q1 2024 · Mar 31 | $340.1M | — | 29.3% | $76.9M | −$56M | — | -1.54 | −$12.1M | $16.6M | −$28.7M | Nov 6 |
| Q4 2023 · Dec 31derived | −$104.9M | — | -31.1% | $88.2M | −$116.8M | — | -3.18 | $46.2M | $29.2M | $17M | Feb 26 |
| Q3 2023 · Sep 30 | $446M | — | 28.9% | $110.4M | $25.2M | — | 0.69 | $105.2M | $33.5M | $71.7M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.2B | 39.5% | $418.7M | −$167.1M | -14.3% | -4.61 | $331.2M | $57.7M | $273.5M | $56.3M | — |
| FY2024 · to Dec 31 | $1.2B | 38.7% | $425.9M | −$430.3M | -35.9% | -11.85 | $128.6M | $77.6M | $51M | $0 | — |
| FY2023 · to Dec 31 | $1.2B | 36.6% | $423.2M | −$5.4M | -0.4% | -0.15 | $205.1M | $109.8M | $95.3M | $92.1M | — |
| FY2022 · to Dec 31 | $1.7B | 34.2% | $452.6M | $211.6M | 12.7% | 5.50 | $313.4M | $142.5M | $170.9M | $145.2M | — |
| FY2021 · to Dec 31 | $1.4B | 36.9% | $422.2M | $118.1M | 8.5% | 2.95 | $293.3M | $103.8M | $189.5M | $109.4M | — |
| FY2020 · to Dec 31 | $1.2B | 38.3% | $397.9M | $181.4M | 14.9% | 4.37 | $352.4M | $82.1M | $270.3M | $88M | — |
Every number comes from Ingevity Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.